医疗广告管理
Search documents
仙游华厦眼科医院被市监处罚 违反医疗广告有关规定
Zhong Guo Jing Ji Wang· 2025-12-29 09:00
华厦眼科(301267.SZ)年报显示,仙游华厦眼科医院有限公司,为公司子公司。 以下为原文: 中国经济网北京12月29日讯 信用中国网站显示,仙游华厦眼科医院有限公司信用信息新增一篇行政处罚决定书(仙市监处罚 ﹝2025﹞293号)。2025年9月10日,仙游县市场监督管理局接到福建省广告监测平台移交的违法广告线索,反映仙游华厦眼科医院 有限公司在微信"仙游华厦眼科"服务号发布违法广告。 2025年9月26日,仙游县市场监督管理局执法人员依法对仙游华厦眼科医院有限公司注册登记住所福建省莆田市仙游县鲤南镇城 南东路966号进行检查。执法人员现场打开微信"仙游华厦眼科"服务号,未发现发布有标题为"侨爱心点亮无声世界白内障手术助五保 户重获光明"的文章,当事人现场承认曾发布过该文章,现已删除,提供了1份文章删除截图。当事人的行为涉嫌违反《医疗广告管理 办法》的有关规定,建议立案调查。 依据《医疗广告管理办法》第二十二条的规定,仙游县市场监督管理局责令当事人改正上述违法行为,对当事人仙游华厦眼科医 院有限公司作如下行政处罚:对当事人发布利用患者、卫生技术人员形象作证明的医疗广告的违法行为,处罚款人民币5000元。以 ...
成都一诊所“50元输液3天”促销?当地通报
券商中国· 2025-06-21 09:56
Core Viewpoint - A clinic in Chengdu's Jinniu District was found to have unlawfully advertised a promotion for intravenous therapy at a price of 50 yuan for three days, leading to an investigation by the local market supervision bureau [1][2]. Group 1: Incident Overview - A video surfaced online showing a clinic in Chengdu's Jinniu District promoting "50 yuan for three days of intravenous therapy," which was confirmed to be true by the local market supervision bureau [1]. - The promotion occurred around March 15, and the clinic did not obtain the required medical advertising review certificate before posting the advertisement [2]. Group 2: Regulatory Response - The Chengdu Jinniu District Market Supervision Administration has initiated an investigation into the clinic for violating the Medical Advertising Management Measures and the Advertising Law of the People's Republic of China [2]. - Following the investigation, the clinic's management stated that the promotion was intended to provide discounts to the public and that they have ceased advertising the promotion after being reported [2]. Group 3: Clinic's Position - The clinic's staff clarified that treatment decisions are based on individual patient needs, and not all patients require intravenous therapy [2]. - The clinic's operator emphasized that the promotion was aimed at benefiting the public and that they are cooperating with the market supervision authorities regarding the matter [2].